Swiss Life Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Buy |
48,988
+4,642
| +10% | +$1.72M | 0.08% | 188 |
|
|
2026
Q1 | $13M | Buy |
44,346
+4,547
| +11% | +$1.49M | 0.06% | 233 |
|
|
2025
Q4 | $14M | Sell |
39,799
-2,828
| -7% | -$956K | 0.07% | 212 |
|
|
2025
Q3 | $13.8M | Sell |
42,627
-5,186
| -11% | -$1.61M | 0.07% | 210 |
|
|
2025
Q2 | $18.6M | Sell |
47,813
-3,836
| -7% | -$1.54M | 0.11% | 147 |
|
|
2025
Q1 | $22.5M | Buy |
51,649
+24,605
| +91% | +$9.88M | 0.16% | 105 |
|
|
2024
Q4 | $9.96M | Sell |
27,044
-2,164
| -7% | -$906K | 0.07% | 198 |
|
|
2024
Q3 | $15.2M | Buy |
29,208
+2,437
| +9% | +$1.3M | 0.17% | 118 |
|
|
2024
Q2 | $14.5M | Buy |
26,771
+8,697
| +48% | +$4.6M | 0.17% | 115 |
|
|
2024
Q1 | $9.37M | Sell |
18,074
-32,865
| -65% | -$16.3M | 0.13% | 145 |
|
|
2023
Q4 | $24M | Buy |
50,939
+14,911
| +41% | +$6.89M | 0.29% | 68 |
|
|
2023
Q3 | $15.7M | Sell |
36,028
-3,725
| -9% | -$1.69M | 0.24% | 91 |
|
|
2023
Q2 | $17.7M | Sell |
39,753
-6,486
| -14% | -$2.99M | 0.26% | 79 |
|
|
2023
Q1 | $21.3M | Sell |
46,239
-12,520
| -21% | -$5.96M | 0.32% | 65 |
|
|
2022
Q4 | $30.2M | Sell |
58,759
-1,862
| -3% | -$945K | 0.5% | 36 |
|
|
2022
Q3 | $27.5M | Buy |
60,621
+1,443
| +2% | +$690K | 0.48% | 36 |
|
|
2022
Q2 | $28.6M | Buy |
59,178
+7,047
| +14% | +$3.49M | 0.46% | 38 |
|
|
2022
Q1 | $25.6M | Sell |
52,131
-2,850
| -5% | -$1.3M | 0.36% | 55 |
|
|
2021
Q4 | $25.5M | Buy |
54,981
+13,831
| +34% | +$5.82M | 0.33% | 67 |
|
|
2021
Q3 | $15.3M | Sell |
41,150
-10,868
| -21% | -$4.13M | 0.21% | 109 |
|
|
2021
Q2 | $19M | Buy |
52,018
+6,200
| +14% | +$2.37M | 0.19% | 94 |
|
|
2021
Q1 | $16.4M | Buy |
45,818
+1,968
| +4% | +$633K | 0.24% | 97 |
|
|
2020
Q4 | $14.1M | Buy |
43,850
+23,261
| +113% | +$7.14M | 0.21% | 106 |
|
|
2020
Q3 | $5.52M | Sell |
20,589
-811
| -4% | -$218K | 0.08% | 183 |
|
|
2020
Q2 | $5.63M | Buy |
21,400
+10,232
| +92% | +$2.73M | 0.09% | 169 |
|
|
2020
Q1 | $2.54M | Buy |
11,168
+413
| +4% | +$113K | 0.05% | 246 |
|
|
2019
Q4 | $3.25M | Sell |
10,755
-601
| -5% | -$165K | 0.06% | 246 |
|
|
2019
Q3 | $2.73M | Sell |
11,356
-8,273
| -42% | -$2.27M | 0.04% | 285 |
|
|
2019
Q2 | $5.53M | Buy |
19,629
+13,703
| +231% | +$3.74M | 0.07% | 175 |
|
|
2019
Q1 | $1.7M | Buy |
5,926
+4,431
| +296% | +$1.28M | 0.02% | 325 |
|
|
2018
Q4 | $393K | Sell |
1,495
-33,750
| -96% | -$9.28M | 0.01% | 177 |
|
|
2018
Q3 | $9.66M | Buy |
35,245
+6,387
| +22% | +$1.66M | 0.13% | 146 |
|
|
2018
Q2 | $6.87M | Sell |
28,858
-7,547
| -21% | -$1.75M | 0.1% | 154 |
|
|
2018
Q1 | $8M | Buy |
36,405
+19,916
| +121% | +$4.68M | 0.14% | 146 |
|
|
2017
Q4 | $3.71M | Buy |
16,489
+789
| +5% | +$168K | 0.08% | 146 |
|
|
2017
Q3 | $2.98M | Buy |
15,700
+1,585
| +11% | +$302K | 0.08% | 167 |
|
|
2017
Q2 | $2.66M | Sell |
14,115
-3,538
| -20% | -$636K | 0.07% | 168 |
|
|
2017
Q1 | $2.92M | Sell |
17,653
-4,538
| -20% | -$722K | 0.08% | 146 |
|
|
2016
Q4 | $3.19M | Sell |
22,191
-3,452
| -13% | -$462K | 0.11% | 123 |
|
|
2016
Q3 | $3.21M | Buy |
25,643
+1,279
| +5% | +$165K | 0.11% | 114 |
|
|
2016
Q2 | $3.2M | Buy |
24,364
+4,275
| +21% | +$585K | 0.13% | 107 |
|
|
2016
Q1 | $2.79M | Buy |
20,089
+8,078
| +67% | +$1.08M | 0.12% | 109 |
|
|
2015
Q4 | $1.67M | Sell |
12,011
-12,006
| -50% | -$1.65M | 0.07% | 113 |
|
|
2015
Q3 | $3.36M | Buy |
24,017
+14,240
| +146% | +$2.14M | 0.16% | 103 |
|
|
2015
Q2 | $1.6M | Buy |
9,777
+2,367
| +32% | +$378K | 0.06% | 125 |
|
|
2015
Q1 | $1.14M | Buy |
+7,410
| New | +$1.05M | 0.05% | 146 |
|
Other funds holding ELV
N
Swiss Life Asset Management's ELV Position: Q2 2026 in Review
Swiss Life Asset Management increased its Elevance Health (ELV) stake by 10% in Q2 2026, buying an estimated $1.72M and bringing the position to 48,988 shares worth $18.9M. The position accounts for 0.08% of the portfolio, ranked #188.
Swiss Life Asset Management first reported a position in ELV in Q1 2015 and has held it in 46 quarters since. The position peaked at $30.2M in Q4 2022. 1,174 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Swiss Life Asset Management held 48,988 shares of Elevance Health worth $18.9M as of Q2 2026.
- Swiss Life Asset Management bought 4,642 Elevance Health shares in Q2 2026, an estimated $1.72M.
- Elevance Health made up 0.08% of Swiss Life Asset Management's portfolio in Q2 2026, its #188 holding.
- Swiss Life Asset Management first reported a position in Elevance Health in Q1 2015 and has held it in 46 quarters since.
- Swiss Life Asset Management's Elevance Health position peaked at $30.2M in Q4 2022.
- 1,174 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.